Status:
UNKNOWN
Xylitol Chewable Tablets Versus Xylitol Chewing Gum in Geriatric Bedridden Patients
Lead Sponsor:
Cairo University
Conditions:
Saliva Altered
Plaque
Eligibility:
All Genders
65+ years
Phase:
EARLY_PHASE1
Brief Summary
This study will be conducted to evaluate the effectiveness of using dissolving Xylitol chewable tablets versus xylitol chewing gum with bedridden geriatric patients in increasing salivary pH and decre...
Detailed Description
This study will be conducted to evaluate the value of using dissolving Xylitol chewable tablets versus xylitol chewing gum with bedridden geriatric patients ,as an alternative to tooth brushing and mo...
Eligibility Criteria
Inclusion
- Age range above 65 years old
- Bedridden patients
- Males or females
- Concious patients
- Co-operative patients approving to participate in the trial.
- Subjects who signed informed consent
Exclusion
- Individuals had taken antibiotics during the last four weeks or anticipated doing so during the study
- Subjects who wore removable prosthesis
- Patients with systemic diseases that have any oral manifestations
- History of Smoking
- Allergy to any of chewing gum or tablets ingredients
- Evidence of tempromandibular joint disorders
- Presence of intraoral infections
- Currently using any mouth rinse
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2021
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT03877705
Start Date
September 1 2019
End Date
January 1 2021
Last Update
March 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of dentistry
Al Manyal, Giza Governorate, Egypt, +02